TIDMGSK

RNS Number : 3167T

GlaxoSmithKline PLC

23 November 2021

   GlaxoSmithKline plc   (the ' Company ') 

Transaction notification

 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  =========================================================================================== 
 a)    Name                                     Dr H Barron 
====  ========================================  ================================================= 
 b)    Position/status                          Chief Scientific Officer and President, 
                                                 R&D 
====  ========================================  ================================================= 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  =========================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ================================================= 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  =========================================================================================== 
 a)    Description of                           American Depositary Shares ('ADSs') 
        the financial 
        instrument                               ISIN: US37733W1053 
====  ========================================  ================================================= 
 b)    Nature of the                            Acquisition of notional ADSs within Dr 
        transaction                              Barron's GSK Executive Supplemental Savings 
                                                 Plan account following the reinvestment 
                                                 of dividends 
====  ========================================  ================================================= 
 c)    Price(s) and                              Price(s)               Volume(s) 
        volume(s) 
====  ========================================   =====================  ======================= 
                                                 $41.5000               2,626.374 
                                                 =====================  ======================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =========================================  ===================================================== 
 e)    Date of the transaction                  2021-11-18 
====  ========================================  ================================================= 
 f)    Place of the                             New York Stock Exchange (XNYS) 
        transaction 
====  ========================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ================================================================================================== 
 a)    Name                                     Dr H Barron 
====  ========================================  ======================================================== 
 b)    Position/status                          Chief Scientific Officer and President, 
                                                 R&D 
====  ========================================  ======================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ======================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ================================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ======================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ======================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ================================================================================================== 
 a)    Description of                           American Depositary Shares ('ADSs') 
        the financial 
        instrument                               ISIN: US37733W1053 
====  ========================================  ======================================================== 
 b)    Nature of the                            Acquisition of ADSs within Dr Barron's 
        transaction                              GSK 401(k) plan account following the reinvestment 
                                                 of dividends 
====  ========================================  ======================================================== 
 c)    Price(s) and                              Price(s)                  Volume(s) 
        volume(s) 
====  ========================================   ========================  =========================== 
                                                 $41.5000                  65 
                                                 ========================  =========================== 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =========================================  ============================================================ 
 e)    Date of the transaction                  2021-11-18 
====  ========================================  ======================================================== 
 f)    Place of the                             New York Stock Exchange (XNYS) 
        transaction 
====  ========================================  ======================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                     Mr J Ford 
====  ========================================  =============================================== 
 b)    Position/status                          SVP & General Counsel 
====  ========================================  =============================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  =============================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  =============================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  =============================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                           American Depositary Shares ('ADSs') 
        the financial 
        instrument                               ISIN: US37733W1053 
====  ========================================  =============================================== 
 b)    Nature of the                            Acquisition of notional ADSs within Mr 
        transaction                              Ford's GSK Executive Supplemental Savings 
                                                 Plan account following the reinvestment 
                                                 of dividends 
====  ========================================  =============================================== 
 c)    Price(s) and                              Price(s)              Volume(s) 
        volume(s) 
====  ========================================   ====================  ====================== 
                                                 $41.5000              62.798 
                                                 ====================  ====================== 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 =========================================  =================================================== 
 e)    Date of the transaction                  2021-11-18 
====  ========================================  =============================================== 
 f)    Place of the                             New York Stock Exchange (XNYS) 
        transaction 
====  ========================================  =============================================== 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHEXLFLFFLBFBE

(END) Dow Jones Newswires

November 23, 2021 10:06 ET (15:06 GMT)

Glaxosmithkline (LSE:GSK)
Historical Stock Chart
From Dec 2021 to Jan 2022 Click Here for more Glaxosmithkline Charts.
Glaxosmithkline (LSE:GSK)
Historical Stock Chart
From Jan 2021 to Jan 2022 Click Here for more Glaxosmithkline Charts.